Abstract
The effects of l-tryptophan (50–800 mg/kg i.p.) on motor activity in mice were studied. l-tryptophan, 800 mg/kg, caused a reduction of motor activity while lower doses had no significant effect. The role of different metabolites of l-tryptophan in behavioural depression was tested by pretreating groups of animals with inhibitors of tryptophan hydroxylase (p-chlorophenylalanine), peripheral aromatic amino acid decarboxylase (DC) (MK-486), peripheral and central DC (NSD 1015), or tryptophan pyrrolase (allopurinol). None of these pretreatments antagonized the l-tryptophan induced depression of motor activity. Pretreatment with MK-486 or NSD-1015 potentiated the depression. Pretreatment with allopurinol potentiated as well as prolonged the depressive effect. Pretreatment with chlorimipramine had no significant effect on the l-tryptophan induced depression. The elevations of brain tryptophan and 5-hydroxytryptamine (5-HT) concentrations after l-tryptophan (800 mg/kg i.p.) were prolonged by pretreatment with allopurinol. The l-tryptophan induced increases in brain concentrations of 5-HT and 5-hydroxyindoleacetic acid were more pronounced after pretreatment with allopurinol. It is suggested that the l-tryptophan induced reduction of motor activity in mice is mediated via the amino acid itself and not via its metabolites.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anden, N.-E., Magnusson, T.: An improved method for the fluorimetric determination of 5-hydroxytryptamine in tissues. Acta physiol. scand. 69, 87–94 (1967).
Ashcroft, G. W., Eccleston, D., Crasford, T. B. B.: 5-hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading-I. J. Neurochem. 12, 483–492 (1965).
Atack, C. V., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmacol. 22, 625–627 (1970).
Bartholini, G., Pletscher, A.: Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylaline. J. Pharm. Pharmacol. 21, 323–324 (1969).
Becking, G. C., Johnson, W. J.: The inhibition of tryptophan pyrrolase by allopurinol, an inhibitor of xanthine oxidase. Canad. J. Biochem. 45, 1667–1672 (1967).
Bedard, P., Carlsson, A., Lindqvist, M.: Effect of transverse hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 1–15 (1972).
Berlet, H. H.: Aspects of amino acid metabolism in phenylketonuria and other amino acidopathies. In: Progress in brain research (W. A. Himwich and J. P. Schade, eds.) vol. 16, pp. 184–213. Amsterdam-London-New York: Elsevier 1965.
Brodie, B. B., Shore, P. A.: A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann. N. Y. Acad. Sci. 66, 631–642 (1957).
Brodie, B. B., Watson, D. R.: Serotonin in brain: functional considerations. In: Advances in pharmacology, vol. 6 B, pp. 97–113 (S. Garattini and P. A. Shore, eds.). New York-London: Academic Press 1968.
Brown, B. B.: CNS drug actions and interaction in mice. Arch. int. Pharmacodyn. 128, 391–414 (1960).
Carlsson, A.: Functional significance of drug-induced changes in brain monoamine levels. In: Progress in brain research, vol. 8, pp. 9–27 (H. E. Himwich and W. A. Himwich, eds.). Amsterdam-London-New York: Elsevier 1964.
Carlsson, A.: Drugs which block the storage of 5-hydroxytryptamine and related amines. In: Handbook of experimental pharmacology, vol. XIX, pp. 529–592 (O. Eichler, and A. Farah, eds.). Berlin-Heidelberg-New York: Springer 1965.
Carlsson, A.: Reporter's remarks. In: Advances in pharmacology, vol. 6 B, pp. 115–119 (S. Garattini and P. A. Shore, eds.). New York-London: Academic Press 1968.
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effects of antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethylmeta-tyramine. Europ. J. Pharmacol. 5, 357–372 (1969a).
Carlsson, A., Jonason, J., Fuxe, K., Lindqvist, M.: Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine. Brain Res. 12, 456–460 (1969b).
Carlsson, A., Lindqvist, M.: The effect of l-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo. J. Neural. Transmission 33, 23–43 (1972).
Coppen, A., Whybrow, P. C., Noguera, R., Maggs, R., Prange, A. J.: The comparative antidepressent value of l-tryptophan and imipramine with and without potentation by liothronine. Arch. gen. Psychiat. 26, 234–241 (1972).
Curzon, G.: Tryptophan pyrrolase—a biochemical factor in depressive illness? Brit. J. Psychiat. 115, 1367–1374 (1969).
Gal, E. M., Poczik, M., Marshall, F. D., Jr.: Hydroxylation of tryptophan to 5-hydroxytryptophan by brain tissue in vivo. Biochem. biophys. Res. Commun. 12, 39–43 (1963).
Grahame-Smith, D. G.: Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and l-tryptophan. J. Neurochem. 18, 1053–1066 (1971).
Grahame-Smith, D. G., Parfitt, A. G.: Tryptophan transport across the synaptosomal membrane. J. Neurochem. 17, 1339–1353 (1970).
Green, A. R., Curzon, G.: The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem. Pharmacol. 19, 2061–2068 (1970).
Greengard, O., Feigelson, P.: The purification and properties of liver tryptophan pyrrolase. J. biol. Chem. 237, 1903–1907 (1962).
Guroff, G., Udenfriend, S.: Studies on aromatic amino acid uptake by rat brain in vivo. J. biol. Chem. 237, 803–806 (1962).
Guroff, G., Lovenberg, W.: Metabolism of aromatic amino acids. In: Handbook of neurochemistry, vol. III, pp. 209–223 (A. Lajtha, ed.). New York-London: Plenum Press 1970.
Hartman, E., Chung, R., Chien, C-p.: l-Tryptophan and sleep. Psychopharmacologia (Berl.) 19, 114–127 (1971).
Hess, S. M., Redfield, B. G., Udenfriend, S.: The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine. J. Pharmacol. exp. Ther. 127, 178–181 (1959).
Jéquier, E., Lovenberg, W., Sjoerdsma, A.: Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Molec. Pharmacol. 3, 274–278 (1967).
Koe, B. K., Weissman, A.: p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. exp. Ther. 154, 499–516 (1966).
Lapin, I. P.: Interaction of kynurenine and its metabolites with tryptamine, serotonin and its precursors and oxotremorine. Psychopharmacologia (Berl.) 26, 237–247 (1972).
Lehmann, J.: Mental and neuromuscular symptoms in tryptophan deficiency. Acta psychiat. scand., Suppl. (in press) (1972).
Lindqvist, M.: Quantitative estimation of 5-hydroxy-3-indole acetic acid and 5-hydroxy-tryptophan in the brain following isolation by means of a strong cation exchange column. Acta pharmacol. (Kbh.) 29, 303–313 (1971).
Meek, J., Fuxe, K., Andén, N.-E.: Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission. Europ. J. Pharmacol. 9, 325–332 (1970).
Modigh, K.: Central and peripheral effects of 5-hydroxytryptophan on motor activity in mice. Psychopharmacologia (Berl.) 23, 48–54 (1972).
Modigh, K.: Effects of chlorimipramine and protryptiline on the hyperactivity induced by 5-hydroxytryptophan after peripheral decarboxylase inhibition in mice. J. Neural. Transmission (in press) (1973).
Modigh, K., Svensson, T. H.: On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome. Brit. J. Pharmacol. 46, 32–45 (1972).
Moir, A. T. B., Eccleston, D.: The effect of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J. Neurochem. 15, 1093–1108 (1968).
Nemeth, A. M.: The effect of 5-fluorouracil on the developmental and adaptive formation of tryptophan pyrrolase. J. biol. Chem. 237, 3703–3706 (1962).
Peters, D. A. V.: Inhibition of brain tryptophan 5-hydroxylase by amino acids — The role of l-tryptophan uptake inhibition. Biochem. Pharmacol. 21, 1051–1053 (1972).
Porter, C. C., Watson, L. S., Titus, D. C., Totaro, J. A., Byer, S. S.: Inhibition of dopa decarboxylase by the hydrazino analog of α-methyldopa. Biochem. Pharmacol. 11, 1067–1077 (1962).
Siegel, S.: Nonparametric statistics. New York: McGraw-Hill 1956.
Udenfriend, S., Clark, C. T., Titus, E.: The presence of 5-hydroxytryptamine in the venom of Bufo marinus Experienta (Basel) 8, 379–380 (1952).
Udenfriend, S., Titus, E., Weissbach, H., Peterson, R. E.: Biogensis and metabolism of 5-hydroxyindole compounds. J. biol. Chem. 219, 335–344 (1956).
Weissbach, H., King, W., Sjoerdsma, A., Udenfriend, S.: Formation of indole-3-acetic acid and tryptamine in animals. J. biol. Chem. 234, 81–86 (1959).
Werle, E., Mennicken, G.: über die Bildung von Tryptamin aus Tryptophan und von Tyramin aus Tyrosin durch tierisches Gewebe. Biochem. Z. 291, 325–327 (1937).
Winer, B. J.: Statistical principles in experimental design. New York: McGraw-Hill 1962.
Wyatt, R. J., Engelman, K., Kupfer, D. J., Fram, D. H., Sjoerdsma, A., Snyder, F.: Effects of l-tryptophan (a natural sedative) on human sleep. Lancet 1970 II, 842–846.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Modigh, K. Effects of l-tryptophan on motor activity in mice. Psychopharmacologia 30, 123–134 (1973). https://doi.org/10.1007/BF00421427
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00421427